These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4564867)

  • 1. Hodgkin's disease and non-Hodgkin's lymphoma--the surgeon's role in therapy.
    Trueblood HW; Guernsey JM; Cohn R
    Curr Probl Surg; 1972 Aug; ():1-36. PubMed ID: 4564867
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical manifestation and chemotherapy in Hodgkin's disease].
    Schmidt CG
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 78(2):140-61. PubMed ID: 4264841
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of Hodgkin's disease and other malignant lymphomas.
    Aungst CW
    J Surg Oncol; 1973 Jun; 5(6):575-9. PubMed ID: 4589653
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma.
    Ihde DC; DeVita VT; Canellos GP; Young RC
    Blood; 1976 Feb; 47(2):211-22. PubMed ID: 1244920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined chemotherapy in disseminated Hodgkin's disease].
    Armata J
    Pol Tyg Lek; 1972 Jul; 27(24):927-9. PubMed ID: 4557231
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of Hodgkin's and non-Hodgkin's lymphomas.
    Sahakian GJ
    Med Clin North Am; 1975 Mar; 59(2):387-97. PubMed ID: 1117771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of malignant lymphomas: a practical and philosophical approach.
    Flexner JM
    South Med J; 1973 Jan; 66(1):4-12. PubMed ID: 4119097
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
    Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
    Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin's disease and other malignant lymphomas.
    Rosenberg SA; Kaplan HS
    Calif Med; 1970 Oct; 113(4):23-38. PubMed ID: 4991356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of survival in Hodgkin's disease.
    Aisenberg AC; Goldman JM
    Cancer; 1971 Apr; 27(4):802-5. PubMed ID: 5574070
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of patients with non-Hodgkin's lymphoma.
    Carbone PP
    Arch Intern Med; 1973 Mar; 131(3):455-9. PubMed ID: 4569377
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined chemotherapy and radiotherapy for advanced Hodgkin's disease and reticulum cell sarcoma: a preliminary report.
    Gamble JF; Fuller LM; Butler JJ; Shullenberger CC
    South Med J; 1971 Jul; 64(7):775-83. PubMed ID: 4933012
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy as a primary treatment of Hodgkin's disease (204 new cases, 1 to 8 years of follow-up).
    Jacquillat C; Weil M; Auclerc G; Desprez-Curely JP; Chastang C; Garçon C; Chantalou JP; Gemon-Auclerc MF; Delobel J; Dana M; Tanzer J; Teillet F; Izrael V; Chelloul N; Weisgerber C; De Heaulme M; Boiron M; Bernard J
    Eur J Cancer (1965); 1975 Oct; 11(10):679-88. PubMed ID: 1204663
    [No Abstract]   [Full Text] [Related]  

  • 14. Single-agent therapy for Hodgkin's disease.
    Carter SK; Livingston RB
    Arch Intern Med; 1973 Mar; 131(3):377-87. PubMed ID: 4631683
    [No Abstract]   [Full Text] [Related]  

  • 15. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
    Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
    J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis and survival with extranodal Hodgkin's disease.
    McLaren JH; Papac RJ
    J Chronic Dis; 1974 Nov; 27(9-10):447-57. PubMed ID: 4139168
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
    Andrieu JM; Casassus P; Coscas Y; Darmont J; Goubeau C; Katz M; Jacquillat C; Tricot G; Weil M
    Bull Cancer; 1982; 69(4):321-9. PubMed ID: 6897520
    [No Abstract]   [Full Text] [Related]  

  • 19. The development of ideas on the natural history and the therapy of Hodgkin's disease.
    Mathé G; Tubiana M
    Ser Haematol; 1973; 6(1):5-19. PubMed ID: 4593777
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].
    Boiron M; Teillet F; Weisgerber C; Dana M; Jacquillat C; Bernard J
    Rev Prat; 1974 Oct; 24(45):3971-8. PubMed ID: 4445767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.